X0303 4 2010-11-02 0 0001339455 Somaxon Pharmaceuticals, Inc. SOMX 0001024004 HALE DAVID F C/O SOMAXON PHARMACEUTICALS, INC. 3570 CARMEL MOUNTAIN ROAD, SUITE 100 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2010-11-02 5 G 0 E 8050 0.00 D 468630 I By Hale Family Trust UTD 2/10/86 Common Stock 2010-11-20 5 G 0 E 550 0.00 D 468080 I By Hale Family Trust UTD 2/10/86 Common Stock 2010-12-01 4 S 0 107893 2.684 D 360187 I By Hale Family Trust UTD 2/10/86 This sale of shares of common stock underlying vested restricted stock units was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, primarily to cover the taxes payable upon the vesting of 203,573 restricted stock units on December 1, 2010. Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $2.64 to $2.73 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. /s/ Matthew W. Onaitis, Attorney-in-fact 2010-12-03